Based on the fully human antibody transgenic RenMab™, RenLite™, and RenNano™ Mice, Biocytogen has integrated its technology platforms in single-cell antibody discovery, gene editing, large-scale disease mouse model supply, and in vivo pharmacology screening to form a new approach to streamline the entire antibody drug discovery and development process. Biocytogen collaborates with global partners to accelerate new drug discovery and development. For more information, please visit www.biocytogen.com
Rules-Based Medicine (RBM), a Q2 Solutions Company, is a CLIA certified, multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services and a novel whole blood immunophenotyping device (TruCulture®). RBM’s internally developed and manufactured immunoassays based on Multi-Analyte Profiling (MAP) and Single-Molecule Array (SimoaTM) ultrasensitive immunoassay technology provides translational and clinical researchers with reproducible and quantitative data for a few or hundreds of human proteins. The comprehensive menu provides extensive coverage of numerous pathways and delivers accurate pharmacodynamic and safety assessments. RBM’s CLIA certified biomarker testing laboratory is located in Austin, TX.
TransCure bioServices (TCS) provides predictive in vivo pharmacology expertise for drug pre-clinical candidate selection in the fields of infectious, cancer (IO, PDX), inflammation, vaccine and immune disease areas. We are the only preclinical CRO providing commercially HIV, immuno-oncology (IO) therapy, PDX, IBD, vaccine and autoimmune mouse models with a fully functional reconstituted HUMAN IMMUNE SYSTEM (hu-mouse models). We co-design study protocols/experiments performing the ordered studies and providing comprehensive data collection, data analysis and reports.
NEBION provides scientists and biomedical researchers with GENEVESTIGATOR®, the premier application for the meta-analysis of public and private gene expression data. Users particularly appreciate the high quality of curated data in combination with the intuitive data mining tools, which they use for the identification and characterization of novel biomarkers and drug targets, prediction of side effects and drug repurposing. Besides the constant expansion and development of GENEVESTIGATOR®, NEBION offers transcriptomics data curation and analysis services.
Flagship Biosciences, Inc. is a technology driven tissue analysis services company delivering the most accurate and informative data for improved drug development. The company offers a full range of tissue analysis services using its award-winning technology to deliver breakthrough contextual data supported by a team of experienced pathology and scientific experts. It caters to pharmaceutical, biotechnology, and clinical diagnostic companies. Flagship Biosciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado. www.flagshipbio.com
PromoCell is the premier manufacturer of cell culture products. PromoCell offers broad range of human primary cells, stem cells and blood cells, optimized cell culture media, and a comprehensive line of cell biology research products. Our cell culture products provide scientists with physiologically accurate models, and therefore enable them to obtain better research results. As the original manufacturer, PromoCell is committed to the highest possible ethical and legal standards
Alloplex Biotherapeutics is a privately held Boston based cellular therapeutics company. Our lead oncology program uses proprietary leukocyte activator cell (LAC) lines, which are engineered from a common tumor cell line to express an array of immunomodulatory ligands designed to specifically engage and activate various components of peripheral blood mononuclear cells (PBMC) through their native receptors. These therapeutic cells have both high potency and tumor specificity. A clinical trial is planned to begin in mid-2020.
HistologiX is a GCP accredited CRO based in the UK. They provide a full range of high quality Histopathology, IHC and Image Analysis services to support Pre-clinical and Clinical R&D, Immuno-oncology and biomarker research. With extensive experience in custom IHC assay development, HistologiX offer brightfield and fluorescent, single or multiplex assay optimisation and validation, and can provide digital image analysis using a wide range of algorithms from the HALO image analysis suite.
GenScript is a world-leading provider of cutting-edge technologies, unparalleled products, and renowned custom services that support life sciences research. Headquartered in New Jersey, with subsidiaries in Europe, Japan, and China, GenScript provides top research services to the global scientific community. Our extensive products portfolio ranges from validated antibodies, cytokines, stable cell lines, surface marker-based cell separation, protein purification magnetic beads, to PCR, gene cloning and gene editing reagents and kits.
We provide off-the-shelf reagents and kits that automate protein analysis processes such as PAGE gel staining, and western blotting. Our innovative magnetic purification technology provides reagents and instruments for automated recombinant protein purification (AmMagTM purification technology) and marker-assisted cell separation (CytoSinctTM cell separation technology). During the ongoing public health emergency generated by the COVID-19 pandemic, GenScript has stepped up and supported scientists and community leaders worldwide by developing key products such as SARS-CoV-2 qRT-PCR detection assays, viral gene-expressing stable cells lines, and more. GenScript’s cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit is the first FDA-EUA authorized kit that specifically detects virus-blocking antibodies in patients’ blood. With such groundbreaking new technologies and an unmitigated commitment to excellence, GenScript helps scientists all over the world accelerate their research.